Singapore — October 15–16, 2025
Professor Marvin H. Caruthers, Co-Founder of ProGenis Pharmaceuticals and world-renowned pioneer in nucleic-acid chemistry, was a featured speaker at RNA Leaders APAC 2025, held at the Sands Expo & Convention Centre, Marina Bay Sands, Singapore.
The event united global leaders and innovators shaping the future of RNA therapeutics and technologies, exploring breakthroughs in mRNA vaccines, oligonucleotide-based therapeutics, and RNA-driven translational medicine.
Professor Caruthers delivered an inspiring session reflecting on his groundbreaking contributions to DNA and RNA chemistry and their transformative impact on modern drug discovery. His insights underscored the vital link between fundamental nucleic-acid research and today’s rapidly evolving RNA therapeutic platforms.
Joining him at the event, Professor Rakesh N. Veedu, Co-Founder and Managing Director of ProGenis Pharmaceuticals, contributed to discussions on emerging translational opportunities in RNA therapeutics, highlighting the company’s thiomorpholino-based RNA chemistry and its application in treating chronic diseases such as type 2 diabetes.
ProGenis Pharmaceuticals is honoured to have its founders among the world’s leading RNA experts and remains committed to advancing next-generation RNA technologies to improve health outcomes globally.
Learn more about the event: https://lnkd.in/gAqzXD38